Brief: Celyad Oncology SA Posts H1 Loss Per Share EUR 0.17

Celyad Oncology SA

04/09/2023 21:03

Sept 4 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY REPORTS FIRST HALF 2023 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * CELYAD ONCOLOGY SA H1 LOSS PER SHARE EUR 0.17
    * CELYAD ONCOLOGY SA - AS OF JUNE 30, 2023, COMPANY HAD CASH
AND
CASH EQUIVALENTS OF EUR 5.0 MILLION

Source text for Eikon:  ID:nGNX9SlsWS 
Further company coverage:  CYAD.BR 

 ((Reuters.Briefs@thomsonreuters.com;))